In the BioHarmony Drug Report Database

"Preview" Icon

Trimethaphan camsylate

Arfonad (trimethaphan camsylate) is a small molecule pharmaceutical. Trimethaphan camsylate was first approved as Arfonad on 1982-01-01. It is used to treat aortic aneurysm, malignant hypertension, and pulmonary edema in the USA.

 

Trade Name

 

Arfonad
 

Common Name

 

trimethaphan camsylate
 

ChEMBL ID

 

CHEMBL1245
 

Indication

 

aortic aneurysm, malignant hypertension, pulmonary edema
 

Drug Class

 

Image (chem structure or protein)

Trimethaphan camsylate structure rendering